Galien Foundation

Home
United States
New York, NY
Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation that improves the state of human health.

Our mission is to serve as a vehicle for the open exchange of ideas that drive science and new innovations. Our vision is to catalyze the development of the next generation of innovative treatment and technologies that will improve health and save lives. Our scope is global, and our commitment to progress in medicine is both measurable and concrete. Our members express this through the establishment of productive relationships to build lasting bridges between the commercial research enterprise and local communities engaged in public policy, science, finance, academic research and the media. Our non-profit 501(c)(3) Foundation oversees and directs activities in the United States for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. Founded in France 50 years ago by pharmacist Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien supports, recognizes and awards the efforts of scientists, researchers and companies committed to advancing medical innovation with the power to change the human condition. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

10/13/2026

𝗧𝗵𝗿𝗲𝗲 𝗟𝗲𝗮𝗱𝗲𝗿𝘀. 𝗢𝗻𝗰𝗲 𝗖𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗩𝗼𝗶𝗰𝗲.
Chair of Prix Galien USA Committee Mike Rosenblatt sits down with Merck Chairman and CEO Rob Davis, and Roche CEO Tom Schinecker, to explore "Stewards of the Enterprise: Access, Supply & Trust" in this exclusive Galien Forum panel on Oct. 29. Register now: https://www.galienfoundation.org/galien-forum-usa-2026-program

10/13/2026

𝗧𝗵𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗿𝘂𝘀𝘁 𝗖𝗼𝗻𝘂𝗻𝗱𝗿𝘂𝗺: 𝗪𝗵𝗲𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗗𝗼𝘂𝗯𝘁𝘀 𝗜𝘁𝘀 𝗢𝘄𝗻 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀
Science is advancing. Why is public confidence struggling to keep pace? From breakthrough medicines to AI, scientific innovation is creating extraordinary opportunities to improve human health. However, scientific achievement alone does not guarantee public understanding, acceptance or confidence.

At the 2026 Galien Patient Summit, a panel of health leaders will explore “The Science Trust Conundrum: When Society Doubts Its Own Progress.” Moderated by Jeremy Levin, Executive Chairman of Ovid Therapeutics, the conversation will feature:

Gil Bashe, Chair Global Health & Purpose, FINN Partners

Julie Fleshman, President & CEO, Pancreatic Cancer Action Network

Margaret (Peggy) Hamburg, MD, Co-President, InterAcademy Partnership and former Commissioner of the U.S. FDA

Vardit Ravitsky, President & CEO, The Hastings Center

The central question: How can science, health, patient advocacy and communications leaders work together so that scientific progress translates into public understanding, better decisions and healthier lives?

Join us on October 29 at the New York Academy of Medicine for this timely conversation, held in partnership with the Galien Patient Summit.

Register: https://www.galienfoundation.org/galien-forum-usa-2026-program

10/13/2026

𝗧𝗵𝗲 𝗪𝗲 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻.
This October 29, USA celebrates 20 years of breakthroughs that have shaped human health, and the teams behind them.
The greatest advances in human health don’t happen alone. They happen when brilliant minds come together to build bigger, move faster, and change more lives.
This is the We Generation.
Because the power of WE is greater than the power of ME.
Thank you Publicis Health for creating a powerful campaign that brought this idea to life.

10/13/2026

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝟮𝟬𝟮𝟲 𝗚𝗮𝗹𝗶𝗲𝗻 𝗪𝗲𝗲𝗸 𝗼𝗳 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿𝘀:
The Best Biotechnology USA Nominees Webinar takes place between 10AM – 11AM ET on Monday, October 26.
This virtual webinar will bring together nominees and allow participants to explore and examine the latest innovations in the biotechnology space.
Register here: https://www.galienfoundation.org/en/galien-week-of-innovation-usa-2026

10/12/2026

𝗧𝗵𝗲 𝗣𝗮𝘁𝗶𝗲𝗻𝘁-𝗙𝗶𝗿𝘀𝘁 𝗣𝗮𝗿𝗮𝗱𝗶𝗴𝗺
This October 29, Scientific American's Vice President & Publisher Jeremy Abbate leads this Galien Patient Summit discussion to understand how patient partnerships are redefining and bringing value to innovation, with:

David Fajgenbaum
Co-Founder & President, Every Cure; Associate Professor of Medicine, University of Pennsylvania

Kathy Giusti
Founder, Multiple Myeloma Research Foundation; Author, Fatal to Fearless

Cheryl Lubbert
CEO & Co-Founder, Reverba Global, an IQVIA business

Kate Sasser
Chief Scientific Officer, Tempus AI

See the full agenda, here: https://bit.ly/4yLOQDm

10/12/2026

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗦𝗸𝗶𝗻 𝗮𝗻𝗱 𝗛𝗮𝗶𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗟𝗣-𝟭 𝗘𝗿𝗮
In one of the industry's most rapidly evolving scientific areas, Scientific American's Vice President & Publisher, Jeremy Abbate, discusses what patients will increasingly expect science to address in the GLP-1 era, with:

Leslie Eden Harris
Chief Strategy Officer for the Medical Aesthetics Incubator Center, L’Oréal Groupe

Magali Moreau
AVP Scientific Direction, Advanced Research, North America and Brazil, L’Oréal Groupe

Julie Russak
Founder, Russak Dermatology Clinic and Russak+ Aesthetic Center

Register now: https://www.galienfoundation.org/galien-forum-usa-2026-program

10/09/2026

𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗶𝘀 𝗮 𝘁𝗲𝗮𝗺 𝗲𝗳𝗳𝗼𝗿𝘁.
For 20 years, has recognized innovations redefining what’s possible in healthcare. Behind each one is a network of people whose shared vision, expertise, and determination turn bold ideas into real-world impact.

On October 29, we celebrate the collective spirit driving human health forward — the We Generation.

Grateful to see this idea brought to life by Publicis Health

10/08/2026

𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗟𝗲𝗮𝗽
Top tier Biopharma CEOs tackle the big challenges and opportunity horizons in this Forum panel on Oct. 29, led by industry expert and Prix Galien USA Committee Chair Ken Frazier, with:

Yvonne Greenstreet
CEO, Alnylam

Olivier Laureau
Chairman & CEO, Servier Group & Servier International Foundation for Research

George Yancopoulos
Co-Founder, President & CSO, Regeneron Pharmaceuticals

Register now: https://www.galienfoundation.org/galien-forum-usa-2026-program

10/07/2026

𝗧𝗵𝗲 𝗪𝗲 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻.
This October 29, USA celebrates 20 years of breakthroughs that have shaped human health, and the teams behind them.

The greatest advances in human health don’t happen alone. They happen when brilliant minds come together to build bigger, move faster, and change more lives.

This is the We Generation.

Because the power of WE is greater than the power of ME.

Thank you Publicis Health for creating a powerful campaign that brought this idea to life.

10/07/2026

𝟮𝟬𝟮𝟲 𝗚𝗮𝗹𝗶𝗲𝗻 𝗪𝗲𝗲𝗸 𝗼𝗳 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗱
Taking place October 26-29, The Galien Foundation will celebrate the 20th Anniversary of USA with a series of virtual webinars and events in New York City. See the full press release: https://prn.to/4y7sDhQ

Address

60 Broad Street
New York, NY
10004

Telephone

+12126851592

Website

http://www.galienfoundation.org/

Alerts

Be the first to know and let us send you an email when Galien Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Galien Foundation:

Featured

Heart River Center for Intuitive Healing

Want your organization to be the top-listed non profit organization in New York?

Galien Foundation

10/13/2026

10/13/2026

10/13/2026

10/13/2026

10/12/2026

10/12/2026

10/09/2026

10/08/2026

10/07/2026

10/07/2026

Address

Telephone

Website

Alerts

Contact The Organization

Shortcuts

Featured

Share

Category

Listing takedown request